Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Find out effective ways to build wealth without investing, utilizing smart financial habits. Start growing your wealth without the risks.
22,750 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
KB Home cuts its full-year outlook after flagging war-related demand weakness, warning that home says already hurting...
As 2026 begins, Tesla faces pressure on deliveries while BYD battles domestic slumps but advances fast charging and o...
As gold holds its bid in a backdrop of steady inflation, the iShares Gold Trust SPDR comparison centers on a 0.15% an...
BuzzFeed shares surged after news that Byron Allen’s family office will take a majority stake. The move could reshape...
Semiconductors have sprinted this year, but a cooling period is drawing attention. History suggests pauses can lead t...
As the Dow breaks above 50,000 in early 2026, investors revisit the ghost 36,000 milestone and debate whether old bet...
Big moves in bonds aren’t always loud. A $15.7 million addition to IBTH reveals NorthCoast’s preference for defined-m...
A fresh round of U.S. quantum funding sparked optimism in the stock market today, lifting IonQ and other quantum play...
Tesla and Nvidia remain market favorites as AI bets diverge. Analysts say one stock currently offers a clearer, more ...
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
In the race to dominate AI inference, two hardware contenders stand out: Nvidia and Cerebras. This guide breaks down ...